0001179110-12-013996.txt : 20120913 0001179110-12-013996.hdr.sgml : 20120913 20120913150656 ACCESSION NUMBER: 0001179110-12-013996 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120912 FILED AS OF DATE: 20120913 DATE AS OF CHANGE: 20120913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis Thomas Andrew CENTRAL INDEX KEY: 0001338185 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 121089981 MAIL ADDRESS: STREET 1: 65 WEST WATKINS MILL ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494-2725 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml FORM 4 - X0306 4 2012-09-12 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001338185 Davis Thomas Andrew C/O CELLDEX THERAPEUTICS, INC. 119 FOURTH AVENUE NEEDHAM MA 02494 0 1 0 0 Sr. VP & CMO Incentive Stock Option 5.69 2012-09-12 4 A 0 115000 0.00 A 2013-09-12 2022-09-12 Common Stock 115000 115000 D 25% vest on September 12, 2013 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. /s/ Avery W. Catlin, attorney in fact for Thomas A. Davis 2012-09-13